CVC wraps up Therakos acquisition

Therakos provides ECP delivery systems for autologous immunomodulatory therapy.

2 December 2024•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.